Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

C. Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-0995-5847; OpenAlex author ID A5084634997. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2013: 2 papers · 2014: 2 papers · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 8

  1. [Interpretation of the surgical treatment of pancreatic cancer of the 2024 edition of the NCCN guidelines]. Co-author DOI 10.3760/cma.j.cn112139-20240315-00127↗
  2. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/bjs.10187↗
  3. MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer. Co-author DOI 10.2174/1566524016666160316154150↗
  4. High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC. Co-author DOI 10.2174/1566524015666150401102218↗
  5. Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer. Co-author DOI 10.1038/onc.2013.223↗
  6. miR-1247 is correlated with prognosis of pancreatic cancer and inhibits cell proliferation by targeting neuropilins. Co-author DOI 10.2174/1566524014666140228120014↗
  7. MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. Co-author DOI 10.2174/1566524011313040001↗
  8. Profilin1 sensitizes pancreatic cancer cells to irradiation by inducing apoptosis and reducing autophagy. Co-author DOI 10.2174/15665240113139990060↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianjun Yu · 8 shared papers, 2013–2024 · strength 0.57
  2. M J Ma · 1 shared paper, 2024 · strength 0.28
  3. Yi Qin · 5 shared papers, 2013–2016 · strength 0.19
  4. Si Shi · 4 shared papers, 2013–2016 · strength 0.15
  5. Jin Xu · 3 shared papers, 2014–2016 · strength 0.14
  6. Cheng He · 3 shared papers, 2013–2015 · strength 0.12
  7. W-Q Wang · 2 shared papers, 2014–2016 · strength 0.09
  8. B. Zhang · 2 shared papers, 2014–2016 · strength 0.09
  9. Chen Liang · 1 shared paper, 2016 · strength 0.05
  10. Wenyan Xu · 1 shared paper, 2016 · strength 0.05
  11. Shunrong Ji · 1 shared paper, 2016 · strength 0.05
  12. Yu Xu · 1 shared paper, 2015 · strength 0.05
  13. Yaolin Xu · 1 shared paper, 2014 · strength 0.04
  14. Lei Liu · 1 shared paper, 2014 · strength 0.04
  15. Thomas S. Frank · 1 shared paper, 2013 · strength 0.03
  16. H. Cheng · 1 shared paper, 2013 · strength 0.03
  17. Jianwei Xu · 1 shared paper, 2013 · strength 0.03
  18. Xiaobo Cui · 1 shared paper, 2013 · strength 0.03
  19. Jingxuan Yang · 1 shared paper, 2013 · strength 0.03
  20. Putao Cen · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.